Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Jun 3, 2026
- Accession no.
- 0001354228-26-000003
- Filed
- Jun 3, 2026
- Trade date
- Jun 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $22.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | SSaleDisposed | −3,876 | $1.54 | −$5,969.04 | 386,879 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −2,264 | $1.54 | −$3,486.56 | 384,615 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −3,539 | $1.54 | −$5,450.06 | 381,076 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −4,915 | $1.54 | −$7,569.1 | 376,161 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.